Zyllt European Union - English - EMA (European Medicines Agency)

zyllt

krka, d.d., novo mesto - clopidogrel (as hydrogen sulfate) - peripheral vascular diseases; stroke; acute coronary syndrome; myocardial infarction - antithrombotic agents - prevention secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.adult patients suffering from acute coronary syndrome:- non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa).- st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy.prevention of atherothrombotic and thromboembolic events in atrial fibrillation:- in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke.

ZOOM WHITENING TOOTHPASTE Canada - English - Health Canada

zoom whitening toothpaste

discus dental, llc - sodium fluoride - toothpaste - 0.243% - sodium fluoride 0.243% - dental agents

ZOOM PROTECTIVE LIP CREAM Canada - English - Health Canada

zoom protective lip cream

discus dental, llc - octinoxate; octisalate; meradimate; oxybenzone - cream - 7.5%; 5%; 5%; 5% - octinoxate 7.5%; octisalate 5%; meradimate 5%; oxybenzone 5% - sunscreen agents